Elicio Therapeutics, Inc. (Nasdaq: ELTX) (“Elicio” or the “Company”) , a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced the ...
Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than ten million ...
A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit ...
Emerging discoveries in liquid biomarker research promise to transform the early detection, diagnosis and treatment ...
Early-age bowel cancer is rising in adults under 50, driven by diet, obesity, and gut microbiome disruption. The post ...
The Public News Service Daily Newscast, July the 6th, 2026. I'm Mike Clifford. Officials say this weekend's extreme heat on ...
While more people are being diagnosed with cancer today compared with 50 years ago, the good news is that fewer people are ...